Patent applications and USPTO patent grants for Miikana Therapeutics, Inc..The latest application filed is for "substituted pyrazole compounds".
Patent | Date |
---|---|
Kinase inhibitors Grant 8,153,630 - Xiao , et al. April 10, 2 | 2012-04-10 |
Method of treating disease states using substituted pyrazole compounds Grant 8,114,870 - Xiao , et al. February 14, 2 | 2012-02-14 |
Substituted Pyrazole Compounds App 20110318393 - Ladouceur; Gaetan ;   et al. | 2011-12-29 |
Inhibitors of histone deacetylase Grant 7,772,245 - Anandan , et al. August 10, 2 | 2010-08-10 |
Substituted pyrazole compounds Grant 7,563,787 - Xiao , et al. July 21, 2 | 2009-07-21 |
Cytotoxic agents and methods of use Grant 7,371,875 - Xiao , et al. May 13, 2 | 2008-05-13 |
Inhibitors of histone deacetylase App 20060199829 - Anandan; Sampath K. ;   et al. | 2006-09-07 |
SEC | 0001300235 | Miikana Therapeutics Inc |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.